Preoperative MELD score predicts mortality and adverse outcomes following radical cystectomy: analysis of American College of Surgeons National Surgical Quality Improvement Program.

IF 2.6 4区 医学 Q2 UROLOGY & NEPHROLOGY
Therapeutic Advances in Urology Pub Date : 2022-11-15 eCollection Date: 2022-01-01 DOI:10.1177/17562872221135944
Christian Habib Ayoub, Ali Dakroub, Jose M El-Asmar, Adel Hajj Ali, Hadi Beaini, Suhaib Abdulfattah, Albert El Hajj
{"title":"Preoperative MELD score predicts mortality and adverse outcomes following radical cystectomy: analysis of American College of Surgeons National Surgical Quality Improvement Program.","authors":"Christian Habib Ayoub, Ali Dakroub, Jose M El-Asmar, Adel Hajj Ali, Hadi Beaini, Suhaib Abdulfattah, Albert El Hajj","doi":"10.1177/17562872221135944","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The model for end-stage liver disease (MELD) has been widely used to predict the mortality and morbidity of various surgical procedures.</p><p><strong>Objectives: </strong>We aimed to correlate a high preoperative MELD score with adverse 30-day postoperative complications following radical cystectomy.</p><p><strong>Design and methods: </strong>Patients who underwent elective, non-emergency radical cystectomy were identified from the American College of Surgeons-National Surgical Quality Improvement Program (ACS-NSQIP) database from 2005 to 2017. Patients were categorized according to a calculated MELD score. The primary outcomes of this study were 30-day postoperative mortality, morbidity, and length of hospital stay following radical cystectomy. For further sensitivity analysis, propensity score matching was used to yield a total of 1387 matched pairs and primary outcomes were also assessed in the matched cohort.</p><p><strong>Results: </strong>Compared with patients with a MELD < 10, those with MELD ⩾ 10 had significantly higher rates of mortality [odds ratio (OR) = 1.71, <i>p =</i> 0.004], major complications (OR = 1.42, <i>p <</i> 0.001), and prolonged hospital stay (OR = 1.29, <i>p <</i> 0.001) on multivariate analysis. Following risk-adjustment for race, propensity-matched groups revealed that patients with MELD score ⩾ 10 were significantly associated with higher mortality (OR = 1.85, <i>p =</i> 0.008), major complications (OR = 1.34, <i>p <</i> 0.001), yet similar length of hospital stay (OR = 1.17, <i>p =</i> 0.072).</p><p><strong>Conclusion: </strong>MELD score ⩾ 10 is associated with higher mortality and morbidity in patients undergoing radical cystectomy compared with lower MELD scores. Risk-stratification using MELD score may assist clinicians in identifying high-risk patients to provide adequate preoperative counseling, optimize perioperative conditions, and even consider nonsurgical alternatives.</p>","PeriodicalId":23010,"journal":{"name":"Therapeutic Advances in Urology","volume":null,"pages":null},"PeriodicalIF":2.6000,"publicationDate":"2022-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/96/8f/10.1177_17562872221135944.PMC9669693.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Therapeutic Advances in Urology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/17562872221135944","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: The model for end-stage liver disease (MELD) has been widely used to predict the mortality and morbidity of various surgical procedures.

Objectives: We aimed to correlate a high preoperative MELD score with adverse 30-day postoperative complications following radical cystectomy.

Design and methods: Patients who underwent elective, non-emergency radical cystectomy were identified from the American College of Surgeons-National Surgical Quality Improvement Program (ACS-NSQIP) database from 2005 to 2017. Patients were categorized according to a calculated MELD score. The primary outcomes of this study were 30-day postoperative mortality, morbidity, and length of hospital stay following radical cystectomy. For further sensitivity analysis, propensity score matching was used to yield a total of 1387 matched pairs and primary outcomes were also assessed in the matched cohort.

Results: Compared with patients with a MELD < 10, those with MELD ⩾ 10 had significantly higher rates of mortality [odds ratio (OR) = 1.71, p = 0.004], major complications (OR = 1.42, p < 0.001), and prolonged hospital stay (OR = 1.29, p < 0.001) on multivariate analysis. Following risk-adjustment for race, propensity-matched groups revealed that patients with MELD score ⩾ 10 were significantly associated with higher mortality (OR = 1.85, p = 0.008), major complications (OR = 1.34, p < 0.001), yet similar length of hospital stay (OR = 1.17, p = 0.072).

Conclusion: MELD score ⩾ 10 is associated with higher mortality and morbidity in patients undergoing radical cystectomy compared with lower MELD scores. Risk-stratification using MELD score may assist clinicians in identifying high-risk patients to provide adequate preoperative counseling, optimize perioperative conditions, and even consider nonsurgical alternatives.

Abstract Image

Abstract Image

Abstract Image

术前 MELD 评分预测根治性膀胱切除术后的死亡率和不良后果:美国外科学院国家外科质量改进计划分析。
背景:终末期肝病模型(MELD终末期肝病模型(MELD)已被广泛用于预测各种外科手术的死亡率和发病率:我们旨在研究术前 MELD 评分高与根治性膀胱切除术后 30 天不良并发症的相关性:我们从美国外科医生学会-国家外科质量改进计划(ACS-NSQIP)数据库中找到了2005年至2017年接受择期、非急诊根治性膀胱切除术的患者。根据计算得出的 MELD 评分对患者进行分类。本研究的主要结果是根治性膀胱切除术后 30 天的术后死亡率、发病率和住院时间。为了进一步进行敏感性分析,研究人员采用倾向评分匹配法,共匹配了1387对患者,并对匹配队列的主要结果进行了评估:与 MELD 患者相比,P = 0.004]、主要并发症(OR = 1.42,P 0.001)和住院时间延长(OR = 1.29,P 0.001)的多变量分析结果。在对种族进行风险调整后,倾向匹配组显示,MELD评分⩾ 10的患者死亡率(OR = 1.85,p = 0.008)和主要并发症(OR = 1.34,p 0.001)显著升高,但住院时间(OR = 1.17,p = 0.072)相似:结论:与较低的MELD评分相比,MELD评分⩾10与接受根治性膀胱切除术的患者死亡率和发病率较高有关。使用 MELD 评分进行风险分级可帮助临床医生识别高风险患者,以便提供充分的术前咨询、优化围手术期条件,甚至考虑非手术替代方案。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
3.70
自引率
0.00%
发文量
39
审稿时长
10 weeks
期刊介绍: Therapeutic Advances in Urology delivers the highest quality peer-reviewed articles, reviews, and scholarly comment on pioneering efforts and innovative studies across all areas of urology. The journal has a strong clinical and pharmacological focus and is aimed at clinicians and researchers in urology, providing a forum in print and online for publishing the highest quality articles in this area. The editors welcome articles of current interest across all areas of urology, including treatment of urological disorders, with a focus on emerging pharmacological therapies.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信